These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24163972)

  • 1. [Viral infection--a diverse causative agent of cancer].
    Pekkonen P; Ojala PM
    Duodecim; 2013; 129(15):1545-51. PubMed ID: 24163972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus infection, cancer & therapy.
    Grm HS; Bergant M; Banks L
    Indian J Med Res; 2009 Sep; 130(3):277-85. PubMed ID: 19901437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection of human papillomaviruses in cancers of different human organ sites.
    Shukla S; Bharti AC; Mahata S; Hussain S; Kumar R; Hedau S; Das BC
    Indian J Med Res; 2009 Sep; 130(3):222-33. PubMed ID: 19901431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillomavirus-like particle vaccines for cervical cancer.
    Schiller JT
    Mol Med Today; 1999 May; 5(5):209-15. PubMed ID: 10322313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey hints at uneven adoption of cancer vaccine.
    Boughton B
    Nat Med; 2008 Jan; 14(1):5. PubMed ID: 18180705
    [No Abstract]   [Full Text] [Related]  

  • 6. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S; Alain S; Denis F
    Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer.
    Palmer KE; Jenson AB; Kouokam JC; Lasnik AB; Ghim SJ
    Exp Mol Pathol; 2009 Jun; 86(3):224-33. PubMed ID: 19454268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human papilloma virus and cervical cancer].
    Berumen-Campos J
    Gac Med Mex; 2006; 142 Suppl 2():51-9. PubMed ID: 19031679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus.
    Ciesielska U; Nowińska K; Podhorska-Okołów M; Dziegiel P
    Adv Clin Exp Med; 2012; 21(2):235-44. PubMed ID: 23214288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus vaccines: current issues & future.
    Kawana K; Yasugi T; Taketani Y
    Indian J Med Res; 2009 Sep; 130(3):341-7. PubMed ID: 19901444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylactic and therapeutic vaccination against human papillomavirus].
    Brun JL; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2007 Nov; 36(7):631-41. PubMed ID: 17822860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
    Mahdavi A; Monk BJ
    Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-human papillomavirus therapeutics: facts & future.
    Bharti AC; Shukla S; Mahata S; Hedau S; Das BC
    Indian J Med Res; 2009 Sep; 130(3):296-310. PubMed ID: 19901439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral infections and human cancers: the legacy of Denis Burkitt.
    Harford JB
    Br J Haematol; 2012 Mar; 156(6):709-18. PubMed ID: 22233526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of human papillomavirus vaccines in cervical neoplasia.
    Stern PL; Faulkner R; Veranes EC; Davidson EJ
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):783-99. PubMed ID: 11563873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
    Khaliq SA; Shyum Naqvi SB; Fatima A
    Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus vaccines for the treatment of cervical cancer.
    Sin JI
    Expert Rev Vaccines; 2006 Dec; 5(6):783-92. PubMed ID: 17184217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multistep carcinogenesis and genital papillomavirus infection. Implications for diagnosis and vaccines.
    Rangel LM; Ramírez M; Torroella M; Pedroza A; Ibarra V; Gariglio P
    Arch Med Res; 1994; 25(2):265-72. PubMed ID: 7919824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.